Acura Pharmaceuticals, Inc (ACUR) insider trading
Every open-market stock purchase and sale by Acura Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Robert B Jones (CEO), $40K, 8 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ACUR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jan 2, 2026 | George K Ross (Director) | Bought (not open market) | — |
| Jan 2, 2026 | George K Ross (Director) | Sold (not open market) | — |
| Jan 2, 2026 | William G Skelly (Director) | Sold (not open market) | — |
| Jan 2, 2026 | Immanuel Thangaraj (Director) | Bought (not open market) | — |
| Jan 2, 2026 | William G Skelly (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Immanuel Thangaraj (Director) | Sold (not open market) | — |
Who's trading ACUR
- George K Ross, Director: other filings, last Jan 2, 2026
- Immanuel Thangaraj, Director: other filings, last Jan 2, 2026
- William G Skelly, Director: other filings, last Jan 2, 2026
Get free alerts when an insider at Acura Pharmaceuticals, Inc files a new trade →